Enhancement of optic nerve lesions has been demonstrated using gadolinium contrast injection. [27, 28] Optic nerve enhancement in acute optic neuritis has been associated with decreased visual ...

Conclusions Optic neuritis is a common initial manifestation of MS. Patients with first demyelinating events who have typical lesions on brain MRI are at increased risk for future events and the ...

METHODS Functional magnetic resonance imaging (fMRI) was used to study the brain activation pattern induced by a periodic monocular 8Hz photic stimulus in seven patients who had recovered from a ...

Acute optic neuritis (ON) typically presents with ocular pain and low visual acuity (VA), and there is a risk of permanent vision loss if ON is not managed properly.1 ON may be the first symptom of ...

Objectives To investigate the differences of clinical features, cerebrospinal fluid (CSF), MRI findings and response to steroid therapies between patients with optic neuritis (ON) who have myelin ...

Aim: To establish the clinical profile of simultaneous bilateral optic neuritis in adults, the efficacy of steroid therapy, extent of visual recovery, and neurological outcome. Methods: The authors ...

Background Little is known about the value of clinical examination in relation to diagnostic imaging for acute groin injuries in athletes. Primary aim: to investigate whether clinical examination ...

Optic nerve hypoplasia: absence of posterior pituitary bright signal on magnetic resonance imaging correlates with diabetes insipidus. (see comments). Am J Ophthalmol 1996; 122: 717–723.

Oculis is advancing its pipeline, including the OCS-05/privosegtor, which showed positive results in the Phase 2 ACUITY trial for acute optic neuritis.

A high-level overview of Oculis Holding AG (OCS) stock. View (OCS) real-time stock price, chart, news, analysis, analyst reviews and more.

Oculis Holding AG hosted its 2025 Annual General Meeting on June 4, 2025, where shareholders approved all agenda items, including the 2024 Annual Report and Financial Statements. The company ...